Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Dementia is increasing in prevalence worldwide, yet frequently remains undiagnosed, especially in low- and middle-income countries. Population-based surveys represent an underinvestigated source to identify individuals at risk of dementia.
BACKGROUND: Amyloid-β peptide (Aβ) is involved in the formation of senile plaques in Alzheimer's disease (AD), and causes neuronal cell death by inducing oxidative stress.
Graphs are widely used as a natural framework that captures interactions between individual elements represented as nodes in a graph. In medical appli...
In recent years, machine learning approaches have been successfully applied to the field of neuroimaging for classification and regression tasks. Howe...
We analyzed the factors associated with dementia in the elderly attended at a memory outpatient clinic of the University of Southern Santa Catarina (U...
Different modalities such as structural MRI, FDG-PET, and CSF have complementary information, which is likely to be very useful for diagnosis of AD an...
The number of people diagnosed with dementia is expected to rise in the coming years. Given that there is currently no definite cure for dementia and ...
BACKGROUND: Diagnosis of Alzheimer's disease (AD) is very important, and MRI is an effective imaging mode of Alzheimer's disease. There are many exist...
OBJECTIVES: To explore whether severity of cognitive impairment and agitation of older people with dementia predict outcomes in engagement, mood state...
Brain-wide and genome-wide association (BW-GWA) study is presented in this paper to identify the associations between the brain imaging phenotypes (i....
BACKGROUND: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) developed a neuropsychological battery (CERAD-NP) to screen patient...
Alzheimer's disease (AD) is a progressive brain disease. The goal of this study is to provide a new computer-vision based technique to detect it in an...
Early diagnosis is critical for individuals with Alzheimer's disease (AD) in clinical practice because its progress is irreversible. In the existing l...
Discriminating Alzheimer's disease (AD) from its prodromal form, mild cognitive impairment (MCI), is a significant clinical problem that may facilitat...
Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) require differential management despite presenting with symptomatic overlap. Currently, t...
To develop a new method for measuring Alzheimer's disease (AD)-specific similarity of cortical atrophy patterns at the individual-level, we employed a...
BACKGROUND: There is a spectrum of the progression from healthy control (HC) to mild cognitive impairment (MCI) without conversion to Alzheimer's dise...
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases with a commonly seen prodromal mild cognitive impairment (MCI) phase whe...
BACKGROUND: The International Challenge for Automated Prediction of MCI from MRI data offered independent, standardized comparison of machine learning...
The depression, anxiety and physiosomatic symptoms (DAPS) of schizophrenia are associated with negative symptoms and changes in tryptophan catabolite ...